Bereich
Gastroenterologie | Hepatologie
GASTRO · Dept. I
Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre
Sawatzki M, Meyenberger C, Brand S, Semela D. Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre. Swiss Med Wkly 2019; 149:w20087.
30.06.2019Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre
30.06.2019Swiss Med Wkly 2019; 149:w20087
Sawatzki Mikael, Meyenberger Christa, Brand Stephan, Semela David
Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study
Brezzi M, Keiser O, Negro F, Semela D, Mullhaupt B, Semmo N, Terziroli Beretta-Piccoli B, Moradpour D, Roelens M, Bertisch B, Swiss Hepatitis C Cohort Study. Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study. PloS one 2019; 14:e0218706.
24.06.2019Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study
24.06.2019PloS one 2019; 14:e0218706
Brezzi Matteo, Keiser Olivia, Negro Francesco, Semela David, Mullhaupt Beat, Semmo Nasser, Terziroli Beretta-Piccoli Benedetta, Moradpour Darius, Roelens Maroussia, Bertisch Barbara, Swiss Hepatitis C Cohort Study
Porto-sinusoidal vascular disease: proposal and description of a novel entity
De Gottardi A, Berzigotti A, Bioulac-Sage P, Primignani M, Semela D, Elkrief L, Bedossa P, Valla D, Garcia-Pagan J, Plessier A, Nery F, Rautou P, Schouten J, Rubbia-Brandt L, Leebeek F, Trebicka J, Murad S, Vilgrain V, Hernandez-Gea V, VALDIG group. Porto-sinusoidal vascular disease: proposal and description of a novel entity. Lancet Gastroenterol Hepatol 2019; 4:399-411.
01.05.2019Porto-sinusoidal vascular disease: proposal and description of a novel entity
01.05.2019Lancet Gastroenterol Hepatol 2019; 4:399-411
De Gottardi Andrea, Berzigotti Annalisa, Bioulac-Sage Paulette, Primignani Massimo, Semela David, Elkrief Laure, Bedossa Pierre, Valla Dominique, Garcia-Pagan Juan Carlos, Plessier Aurélie, Nery Filipe, Rautou Pierre-Emmanuel, Schouten Jeoffrey, Rubbia-Brandt Laura, Leebeek Frank, Trebicka Jonel, Murad Sarwa Darwish, Vilgrain Valérie, Hernandez-Gea Virginia, VALDIG group
Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents
Terziroli Beretta-Piccoli B, Muratori L, Vergani D, Mieli-Vergani G, Moradpour D, Semela D, Semmo N, Mertens J, Cerny A, Melidona L, Tesei C, Silvestri T, Grondona A, Deleonardi G, Di Bartolomeo C, Swiss Hepatitis C Cohort Study. Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents. J Autoimmun 2019; 102:89-95.
30.04.2019Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents
30.04.2019J Autoimmun 2019; 102:89-95
Terziroli Beretta-Piccoli Benedetta, Muratori Luigi, Vergani Diego, Mieli-Vergani Giorgina, Moradpour Darius, Semela David, Semmo Nasser, Mertens Joachim, Cerny Andreas, Melidona Laura, Tesei Cinzia, Silvestri Tania, Grondona Ana Gabriela, Deleonardi Gaia, Di Bartolomeo Claudia, Swiss Hepatitis C Cohort Study
Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience
Baumeler S, Jochum W, Neuweiler J, Bergamin I, Semela D. Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience. Swiss Med Wkly 2019; 149:w20077.
26.04.2019Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience
26.04.2019Swiss Med Wkly 2019; 149:w20077
Baumeler Stephan, Jochum Wolfram, Neuweiler Jörg, Bergamin Irina, Semela David
SDF-1/CXCR4 signalling is involved in blood vessel growth and remodelling by intussusception
Dimova I, Karthik S, Makanya A, Hlushchuk R, Semela D, Volarevic V, Djonov V. SDF-1/CXCR4 signalling is involved in blood vessel growth and remodelling by intussusception. J Cell Mol Med 2019; 23:3916-3926.
04.04.2019SDF-1/CXCR4 signalling is involved in blood vessel growth and remodelling by intussusception
04.04.2019J Cell Mol Med 2019; 23:3916-3926
Dimova Ivanka, Karthik Swapna, Makanya Andrew, Hlushchuk Ruslan, Semela David, Volarevic Vladislav, Djonov Valentin
Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?
Bertisch B, Keiser O, Moradpour D, Zehnder C, Marinucci F, Roelens M, Moriggia A, Clerc O, Giudici F, Schmid P, Künzler-Heule P, Ottiger C, Mullhaupt B, Negro F, Brezzi M, Swiss Hepatitis C Cohort Study. Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?. Clin Infect Dis 2019
03.04.2019Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?
03.04.2019Clin Infect Dis 2019
Bertisch Barbara, Keiser Olivia, Moradpour Darius, Zehnder Cinzia, Marinucci Francesco, Roelens Maroussia, Moriggia Alberto, Clerc Olivier, Giudici Fabio, Schmid Patrick, Künzler-Heule Patrizia, Ottiger Cornelia, Mullhaupt Beat, Negro Francesco, Brezzi Matteo, Swiss Hepatitis C Cohort Study
Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions
Rusch U, Robbins S, Razavi H, Vernazza P, Blach S, Bruggmann P, Mullhaupt B, Negro F, Semela D. Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions. Swiss Med Wkly 2019; 149:w14694.
23.01.2019Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions
23.01.2019Swiss Med Wkly 2019; 149:w14694
Rusch Urs, Robbins Sarah, Razavi Homie, Vernazza Pietro, Blach Sarah, Bruggmann Philip, Mullhaupt Beat, Negro Francesco, Semela David
Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
Mullhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, Robbins Scott S, Semela D, Negro F. Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?. PloS one 2018; 13:e0209374.
31.12.2018Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
31.12.2018PloS one 2018; 13:e0209374
Mullhaupt Beat, Bruggmann Philip, Bihl Florian, Blach Sarah, Lavanchy Daniel, Razavi Homie, Robbins Scott Sarah, Semela David, Negro Francesco
Comparison of the diagnostic accuracy of contrast – enhanced ultrasound (CEUS) within 5 minutes and CT/MRI for diagnosing vital tumor tissue after RFA/TACE in HCC and liver metastasis in a tertiary Swiss GI center
Sawatzki M (2018). Comparison of the diagnostic accuracy of contrast – enhanced ultrasound (CEUS) within 5 minutes and CT/MRI for diagnosing vital tumor tissue after RFA/TACE in HCC and liver metastasis in a tertiary Swiss GI center.
15.11.2018Comparison of the diagnostic accuracy of contrast – enhanced ultrasound (CEUS) within 5 minutes and CT/MRI for diagnosing vital tumor tissue after RFA/TACE in HCC and liver metastasis in a tertiary Swiss GI center
15.11.2018Interdisziplinärer Ultraschall Dreiländertreffen
Sawatzki Mikael
DIagnosis of typical nodular hyperplasia in the liver - use of a novel ultrasonic vascular Doppler technique
Sawatzki M, Semela D, Neuweiler J, Brand S (2018). DIagnosis of typical nodular hyperplasia in the liver - use of a novel ultrasonic vascular Doppler technique.
22.10.2018DIagnosis of typical nodular hyperplasia in the liver - use of a novel ultrasonic vascular Doppler technique
22.10.2018UEGW
Sawatzki Mikael, Semela David, Neuweiler Jörg, Brand Stephan
Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study
Geier A, Mullhaupt B, Bischoff-Ferrari H, Saleh L, Marques Maggio E, Jahn D, Bantel H, Tschopp O, Seifert B, Tay F, Semela D, Stirnimann G, Eichinger M, Dufour J. Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study. Scand J Gastroenterol 2018:1-7.
29.09.2018Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study
29.09.2018Scand J Gastroenterol 2018:1-7
Geier Andreas, Mullhaupt Beat, Bischoff-Ferrari Heike A, Saleh Lanja, Marques Maggio Ewerton, Jahn Daniel, Bantel Heike, Tschopp Oliver, Seifert Burkhardt, Tay Fabian, Semela David, Stirnimann Guido, Eichinger Mareile, Dufour Jean-François
Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer
Frei N, Frei R, Semadeni G, Jochum W, Brand S, Borovicka J. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer. Digestion 2018; 99:293-300.
03.09.2018Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer
03.09.2018Digestion 2018; 99:293-300
Frei Nicola Fabian, Frei Remus, Semadeni Gian-Marco, Jochum Wolfram, Brand Stephan, Borovicka Jan
High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men
Braun D, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard H, Böni J, Fehr J, Nicca D, Künzler-Heule P, Hampel B, Kouyos R, Nguyen H, Shah C, Flepp M, Stöckle M, Conen A, Béguelin C, Swiss HIV Cohort Study. High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men. Clin Infect Dis 2018
13.08.2018High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men
13.08.2018Clin Infect Dis 2018
Braun Dominique L, Schmid Patrick, Delaloye Julie, Rougemont Mathieu, Bernasconi Enos, Rauch Andri, Günthard Huldrych F, Böni Jürg, Fehr Jan S, Nicca Dunja, Künzler-Heule Patrizia, Hampel Benjamin, Kouyos Roger, Nguyen Huyen, Shah Cyril, Flepp Markus, Stöckle Marcel, Conen Anna, Béguelin Charles, Swiss HIV Cohort Study
The Drill and Blast Procedure - or How to Treat Complicated Bouveret’s Syndrome Endoscopically
Bertolini R, Gubler C. The Drill and Blast Procedure - or How to Treat Complicated Bouveret’s Syndrome Endoscopically. Journal of Digestive Diseases and Hepatology 2018; J Dig Dis Hepatol: JDDH-151
27.07.2018The Drill and Blast Procedure - or How to Treat Complicated Bouveret’s Syndrome Endoscopically
27.07.2018Journal of Digestive Diseases and Hepatology 2018; J Dig Dis Hepatol: JDDH-151
Bertolini Reto, Gubler Christopf
Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept
Popp F, Semela D, von Kempis J, Mueller R. Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept. BMJ Case Rep 2018; 2018
12.05.2018Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept
12.05.2018BMJ Case Rep 2018; 2018
Popp Florian, Semela David, von Kempis Johannes, Mueller Ruediger B
Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review
Goossens N, Semmo N, Mullhaupt B, Semela D, Malinverni R, Moradpour D, Heim M, Trincucci G, Rubbia-Brandt L, Negro F, Wedemeyer H, Adinolfi L, de Vito C, Mangia A, Clément S, Cenderello G, Barrera F, D'Ambrosio R, Coppola N, Zampino R, Stanzione M, BOSTIC Study Group. Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review. J Viral Hepat 2018; 25:920-929.
17.04.2018Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review
17.04.2018J Viral Hepat 2018; 25:920-929
Goossens N, Semmo N, Mullhaupt B, Semela David, Malinverni R, Moradpour D, Heim M, Trincucci G, Rubbia-Brandt L, Negro F, Wedemeyer H, Adinolfi L E, de Vito C, Mangia A, Clément S, Cenderello G, Barrera F, D'Ambrosio R, Coppola N, Zampino R, Stanzione M, BOSTIC Study Group
Endoscopic full thickness resection (EFTR) of colorectal neoplasms with the Full Thickness Resection Device (FTRD): Clinical experience from two tertiary referral centers in Switzerland
Frei R. Endoscopic full thickness resection (EFTR) of colorectal neoplasms with the Full Thickness Resection Device (FTRD): Clinical experience from two tertiary referral centers in Switzerland. United European Gastroenterol Journal 2018; 2018 Apr;6(3):463-470.
04.04.2018Endoscopic full thickness resection (EFTR) of colorectal neoplasms with the Full Thickness Resection Device (FTRD): Clinical experience from two tertiary referral centers in Switzerland
04.04.2018United European Gastroenterol Journal 2018; 2018 Apr;6(3):463-470
Frei Remus
SEECS group.Cohort Profile: The Swiss Eosinophilic Esophagitis
Schoepfer A, Juillerat P, Biedermann L, Vavricka S, Sawatzki M, Aepli P, Hruz P, Safroneeva E, Saner c, Straumann A. SEECS group.Cohort Profile: The Swiss Eosinophilic Esophagitis. Inflammatory Intestinal Diseases 2018; 2:163-170.
31.01.2018SEECS group.Cohort Profile: The Swiss Eosinophilic Esophagitis
31.01.2018Inflammatory Intestinal Diseases 2018; 2:163-170
Schoepfer Alain, Juillerat P, Biedermann L, Vavricka S, Sawatzki Mikael, Aepli P, Hruz P, Safroneeva E, Saner c, Straumann A
Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
Bachofner J, Mertens J, Terziroli Beretta-Piccoli B, Mullhaupt B, Magenta L, Semela D, Fehr J, Moncsek A, Seifert B, Braun D, Baserga A, Künzler-Heule P, Kröger A, Bergamin I, Valli P, The Swiss Hepatitis C Cohort Study. Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland. Swiss Med Wkly 2018; 148:w14560.
18.01.2018Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
18.01.2018Swiss Med Wkly 2018; 148:w14560
Bachofner Jacqueline, Mertens Joachim, Terziroli Beretta-Piccoli Benedetta, Mullhaupt Beat, Magenta Lorenzo, Semela David, Fehr Jan, Moncsek Anja, Seifert Burkhardt, Braun Dominique L, Baserga Adriana, Künzler-Heule Patrizia, Kröger Arne, Bergamin Irina, Valli Piero V, The Swiss Hepatitis C Cohort Study